Skip to content

LivaNova LIVN EBITDA margin

EBITDA margin at other companies

Abbott logo
AbbottABT
24.1%-0.2pp
Haemonetics logo
HaemoneticsHAE
27.6%+6.1pp
Medtronic logo
MedtronicMDT
25.9%-0.4pp
ResMed logo
ResMedRMD
38.2%+2.5pp
Boston Scientific logo
Boston ScientificBSX
25.2%+1.6pp
Stryker logo
StrykerSYK
24.6%+4.7pp

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

Based on trailing twelve months.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's EBITDA margin?
LivaNova (LIVN) reported EBITDA margin of 16.8% in Q1 2026.
How has LivaNova's EBITDA margin changed year-over-year?
LivaNova's EBITDA margin increased by 8.3% year-over-year, from 15.5% to 16.8%.
What is the long-term trend for LivaNova's EBITDA margin?
Over 5 years (2020 to 2025), LivaNova's EBITDA margin has grown at a -6.0% compound annual growth rate (CAGR), from -24.1% to 17.7%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.